期刊文献+

血清总胆固醇与高密度脂蛋白胆固醇比值作为冠心病危险标志的意义 被引量:7

Significance of serum total cholesterol to high density lipoprotein cholesterol ratio as a risk marker for coronary heart disease
下载PDF
导出
摘要 目的分析冠心病(CHD)患者的血脂水平,探讨血清总胆固醇(TC)与高密度脂蛋白胆固醇(HDL-C)比值作为CHD危险标志的临床意义。方法测定295例CHD患者的血清TC、三酰甘油(TG)、HDL-C及低密度脂蛋白胆固醇(LDL-C)水平,并计算TC/HDL-C比值。结果依据《中国成人血脂异常防治指南》颁布的血脂水平合适范围,CHD患者血清TC、TG及LDLC高于合适范围百分率分别为32.20%、34.24%及37.63%,血清HDL-C低于合适范围百分率为39.32%。血清TC/HDL-C比值高于合适范围百分率为57.29%。血清TC/HDL-C比值异常率显著高于血清TC、TG、HDL-C及LDL-C(χ2=37.540、31.576、19.066、22.866,P<0.01)。结论与任一单项血脂检测相比,血清TC/HDL-C比值作为CHD危险标志可能更有临床意义,临床血脂检测报告单应增加TC/HDL-C比值。 Objective To analyze blood lipid levels in patients with coronary heart disease,and to explore clinical significance of serum total cholesterol to high density lipoprotein cholesterol ratio as a risk marker for coronary heart disease.Methods Serum levels of total cholesterol,triglycerides,high density lipoprotein cholesterol,and low density lipoprotein cholesterol were measured for295 patients with coronary heart disease.Ratio of total cholesterol to high density lipoprotein cholesterol was calculated based on the lipid tests.Results The percentages of abnormal total cholesterol,triglycerides,high density lipoprotein cholesterol,and low density lipoprotein cholesterol were 32.20%、34.24%,39.32%,and 37.63%,respectively,for patients with coronary heart disease according to normal ranges issued by Guidelines on Prevention and Treatment of Dyslipidemia in Adults in Chinese Population.The abnormal percentage of total cholesterol to high density lipoprotein cholesterol ratio was 57.29%.The percentage of raising total cholesterol to high density lipoprotein cholesterol ratio was significantly higher than abnormal ratios of total cholesterol,triglycerides,high density lipoprotein cholesterol,and low density lipoprotein cholesterol for patients with coronary heart disease(χ^2=37.540,31.576,19.066,22.866;P〈0.01).Conclusion Comparing to any blood lipid test,total cholesterol to high density lipoprotein cholesterol ratio is a marker that helps us estimate the risk of developing coronary heart disease.Ratio of total cholesterol to high density lipoprotein cholesterol may be as a test estimating the risk of developing coronary heart disease.
作者 李璐 纪玲
出处 《国际检验医学杂志》 CAS 2015年第14期2034-2035,2037,共3页 International Journal of Laboratory Medicine
关键词 冠心病 总胆固醇 高密度脂蛋白胆固醇 比值 coronary heart disease total cholesterol high density lipoprotein cholesterol ratio
  • 相关文献

参考文献14

  • 1Suh B, Shin DW,Lee SP, et al. Family history of coronary heart disease is more strongly associated with coronary than with carot- id atherosclerosis in healthy asymptomatie adults[J]. Atheroscle- rosis,2014,233(2) :584-589.
  • 2Hisamatsu T, Fujiyoshi A, Miura K, et al. Lipoprotein particle profiles compared with standard lipids in association with coro- nary artery calcification in the general Japanese population [J]. Atherosclerosis,2014,236 (2) :237-243.
  • 3Shakeri H, Hadaegh H, Abedi F, et al. Consumption of synbiotic bread decreases triacylglycerol and VLDL levels while increasing HDL levels in serum from patients with type-2 diabetes[J]. Lip- ids,2014,49(7) :695-701.
  • 4Nejat A,Mirbolouk M,Mohebi R,et al. Changes in lipid measures and incident coronary heart disease: Tehran Lipid : Glucose Study[J]. Clin Biochem, 2014,47(13) : 1239-1244.
  • 5胡大一,丁荣晶.《中国成人血脂异常防治指南》解读[J].中华内科杂志,2008,47(9):723-724. 被引量:35
  • 6许丽霞,周红,邹丽娥.不同剂量瑞舒伐他汀对冠心病合并高胆固醇血症患者血脂及血清hs-CRP的影响[J].海南医学,2014,25(14):2093-2095. 被引量:13
  • 7Greenwood JP, Motwani M, Maredia N, et al. Comparison of car- diovascular magnetic resonance and single-photon emission com- puted tomography in women with suspected coronary artery dis- ease from the Clinical Evaluation of Magnetic Resonance Imaging in Coronary Heart Disease (CE-MARC) Trial[J]. Circulation, 2014,129(10) : 1129-1138.
  • 8Kizer JR, Benkeser D, Arnold AM, et alo Advanced glycation/gly- coxidation endproduct carboxymethyl-lysine and incidence of coro- nary heart disease and stroke in older adults[J]. Atherosclerosis, 2014,235(1) :116-121.
  • 9Russo GT,Giandalia A,Romeo EL, et al. Lipid and non-lipid car- diovascular risk factors in postmenopausal type 2 diabetic women with and without coronary heart disease[J]. J Endocrinol Invest, 2014,37(3) :261-268.
  • 10Tehrani DM, Gardin JM, Yanez D, et al. Impact of inflammatory biomarkers on relation of high density lipoprotein-cbolesterol with incident coronary heart disease:cardiovascular health study[J]. Atheroselerosis,2013,231(2) :246-251.

二级参考文献13

  • 1Rosuvastatin Registration Clinical Trial Group.Cardiovascular Institute and Fu Wai Hospital,Peking Union Medical College and Chinese Academy of Medical Science,Beijing 100037,China.瑞舒伐他汀治疗中国高胆固醇血症患者疗效和安全性的随机双盲多中心对照研究[J].中华心血管病杂志,2007,35(3):207-211. 被引量:117
  • 2中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5221
  • 3National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults ( Adult Treatment Panel Ⅲ). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults ( Adult Treatment Panel Ⅲ) final report. Circulation, 2002,106:3143-3421.
  • 4方圻,王钟林,宁田海,邵耕,陈在嘉,陆宗良,李健斋,林传骧,周北凡,诸骏仁,诸永康,陶萍,陶寿淇,龚兰生,顾复生,游凯,戴玉华.血脂异常防治建议[J].中华心血管病杂志,1997,25(3):169-175. 被引量:3067
  • 5Jacqueline S, Daniel I, Jean G, et al. Lack of association between SLCO1B1 polymorphisms and clinical myalgia following rosuvas- tatin therapy [J]. American Heart Journal, 2013, 165(6): 1008-1014.
  • 6Gianluigi S, Francesca M, Massimo V, et al. Effects of atorvastatin and rosuvastatin on renal function: A meta-analysis [J]. Internation- al Journal of Cardiology, 2013, 167(6): 2482-2489.
  • 7Rajkimn M, Deepa K. Pleiotropic antioxidant potential of rosuvas- tatin in preventing cardiovascular disorders [J]. European Journal of Pharmacology, 2011, 71(3): 57-62.
  • 8Huang B, Wu CH, Li FA, et al. Rosuvastatin-regulated post-transla- tional phosphoproteome in human umbilical vein endothelial cells [J]. The Kaohsiung Journal of Medical Sciences, 2012, 29(7): 347-352.
  • 9Christie M, Ron C, Joe L, et al. Efficacy, safety and effect on bio- markers related to cholesterol and lipoprotein metabolism of rosuv- astatin 10 or 20 mg plus ezetimibe 10 mg vs. simvastatin 40 or 80 nag plus ezetimibe 10 mg in high-risk patients: Results of the GRAVITY randomized study [J]. American Journal of Obstetrics and Gynecology, 2013, 232(1): 86-93.
  • 10Yogo M, Sasaki M, Ayaori M, et al. Intensive lipid lowering therapy with titrated rosuvastatin yields greater atherosclerotic aortic plaque regression: Serial magnetic resonance imaging observations from RAPID study [J]. Asian Journal of medical microbiology, 2011, 56 (12): 1625-1629.

共引文献46

同被引文献100

  • 1张慧平,孙福成,王抒.高密度脂蛋白与动脉粥样硬化和冠心病[J].中国动脉硬化杂志,2004,12(6):733-736. 被引量:22
  • 2施学莲,王爱丰,王正伦.社区老年人慢性病患病与生活方式的关系——基于江苏省十三市县的实证调查[J].中国老年学杂志,2014,34(1):172-173. 被引量:24
  • 3中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5221
  • 4陈文彬,潘详林.诊断学[M].北京:人民卫生出版社,2008:52-54.
  • 5查锡良.生物化学[M].北京:人民卫生出版社,2008.4.
  • 6王安利.运动医学[M].北京:人民体育出版社,2007.
  • 7Charles B.Corbin, Gregory J. Welk, et al. Fundamental Concepts of Fimess and Wellness (2~) [M]. New York, The McGraw. Hill Companies, 2006:91-102.
  • 8m Gavriilaki,E, Douma,S.Eft~cts of Acute and Chronic Exercise l~ in Patients With Essential Hypertension: Benefits and Risks [J]. Am J Hypertens, 2014,28(6):429-439.
  • 9James, P. A,Oparil, S,Carter, B. L, et al. evidence-based guide- line for the management of high blood pressure in adults: report fi'om the panel members appointed to the Eighth Joint National Committee (JNC 8) [J]. Jama, 2014,311(5): 507-520.
  • 10Maruf, F. A, Salako, B. L, Akinpelu, A. O. Can aerobic exer- cise complement antihypertensive drugs to achieve blood pres- sure control in individuals with essential hypertension? [J]. J Cardiovasc Med (Hagerstown), 2014,15(6):456-462.

引证文献7

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部